Skip to main content
ISTH 2023 Main banner
Back

    Glenn F. Pierce, MD PhD

    VP Medical
    World Federation of Hemophilia
    Montreal, Quebec, Canada

    Glenn Pierce, MD PhD, Vice President Medical, World Federation of Hemophilia.
    Glenn is independent biotech consultant and entrepreneur-in-residence at Third Rock Ventures. He has over 35 years’ experience in developing new therapeutic medicines and led development of the first extended half-life FVIII and FIX products. He co-founded Ambys Medicines and is director of Voyager Therapeutics and former director of Global Blood Therapeutics.
    Dr. Pierce lived with severe hemophilia A until 2008. He serves on NHF-MASAC and is the elected VP Medical for WFH. At WFH, he has co-developed the expanded humanitarian aid program, World Bleeding Disorders Registry, WFH Gene Therapy Registry, and the latest edition of WFH Guidelines for the Treatment of Hemophilia. He received an M.D. and a Ph.D. in Immunology, both from Case Western Reserve University in Cleveland, Ohio and did his postgraduate training in pathology and hematology research at Washington University in St. Louis, Missouri. Glenn splits time between La Jolla and San Francisco.

    Presentation(s):